Filing Details
- Accession Number:
- 0001110803-15-000047
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-02 21:26:49
- Reporting Period:
- 2015-01-29
- Filing Date:
- 2015-02-02
- Accepted Time:
- 2015-02-02 21:26:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1566173 | Michel Bouchard | 5200 Illumina Way San Diego CA 92122 | Vp, Finance & Chief Accounting | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-01-29 | 519 | $200.00 | 25,515 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-01-29 | 247 | $200.00 | 25,268 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-01-31 | 448 | $194.77 | 24,820 | No | 4 | F | Direct | |
Common Stock | Acquisiton | 2015-02-02 | 632 | $69.34 | 25,452 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-02-02 | 632 | $195.37 | 24,820 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-02-02 | 632 | $0.00 | 632 | $69.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-02-28 | 2021-01-31 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.